Product Updates
July 15, 2022
ImpriMed releases a new generation of artificial intelligence models
On June 27th, ImpriMed's Data Science team released a new generation of AI models for canine lymphoma with improved predictive performance. The models, which predict the likelihood of a positive clinical response to 10 different chemotherapy drugs, were optimized to give higher sensitivity and...
Read More →